Andere Sprachen Scancell Holdings plc

Aktien

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:01 13.05.2024			% 5 Tage	% 1. Jan.
9,875 ^GBX	0,00 %		+7,92 %	-5,95 %

26.03.	Scancell verabreicht ersten Patienten in Melanom-Studie	AN
22.03.	Seneca Growth Capital gibt laue Ergebnisse für 2023 bekannt	AN

Scancell doses first patient in melanoma-focused trials	26.03.
Seneca Growth Capital announces tepid 2023 results	22.03.
Scancell Holdings plc Appoints Sath Nirmalananthan to the Board	14.03.
Alliance Pharma appoints chair; FireAngel sales down	05.02.
Scancell's Chief Development Officer to Step Down	05.02.
Scancell Holdings plc Directorate and Executive Changes Changes	05.02.
Scancell interim loss narrows amid finance gain on derivative	30.01.
Scancell Holdings plc Reports Earnings Results for the Half Year Ended October 31, 2023	30.01.
Scancell approved by MHRA to add new cohort to Scope trial	17.01.
Scancell Holdings plc Announces Update on SCOPE Trial	17.01.
Scancell Raises GBP1.2 Million Via Open Offer	19.12.
Scancell raises GBP12 million in total from fundraise	19.12.
Scancell Raises GBP11 Million via Share Issue	01.12.
Scancell raises GBP10.7 million in upsized share sale	01.12.
EARNINGS AND TRADING: Dispensa and SkinBioTherapeutics losses widen	30.11.
Scancell’s Skin Cancer Vaccine Trial Advances to Second Stage; Shares Up	28.11.
Scancell trial progresses; OptiBiotix inks new deal	28.11.
Scancell shares up as presents "trailblazing" trial data	10.11.
EARNINGS: Frontier IP chair to step down; "busy" Rosslyn narrows loss	31.10.23
Earnings Flash (SCLP.L) SCANCELL HOLDINGS Reports FY23 Revenue GBP5.3M	31.10.23

Keine Ergebnisse zu dieser Suche